Antitrust Antitrust

Comment: Pharmacy benefit managers’ contracting practices criticized in submissions to US FTC

By Max Fillion and Khushita Vasant
  • 11 Oct 2021 18:45
  • 11 Oct 2021 20:01
Pharmacy benefit managers’ contracting practices were attacked as anticompetitive in submissions by pharmacist industry groups to the US Federal Trade Commission as part of the agency’s inquiry into unfair contract terms.

PBMs have received increasing scrutiny in recent years as lawmakers and regulators contemplate reforms aimed at boosting competition in US

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News